Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Centre Rene Gauducheau, Nantes, France
New findings from France, the South Korea and Poland in the area of rectal cancer detailed
August 18th, 2006
Data on rectal cancer are outlined in reports from France, the South Korea and Poland. Study 1: A delay of more than 16 weeks between diagnosis and surgery may decrease survival in rectal cancer patients treated with preoperative radiotherapy (RT). "In Europe, until recently the standard treatment for locally advanced rectal cancer was preoperative RT. The objective of this study was to evaluate the influence on survival of intervals between diagnosis and treatment. The influence on survival of intervals between diagnosis and surgery (Dg-Surg), diagnosis and initiation of RT (Dg-Rad), and completion of RT and surgery (Rad-Surg) was evaluated in a...
Source: Biotech Law Weekly (2006-08-18)
|
